Actinium Pharmaceuticals Inc (ATNM)
9.80
-0.05
(-0.51%)
USD |
NYAM |
May 17, 16:00
9.75
-0.05
(-0.51%)
After-Hours: 20:00
Actinium Pharmaceuticals Market Cap: 291.88M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 291.88M |
| May 16, 2024 | 293.37M |
| May 15, 2024 | 289.79M |
| May 14, 2024 | 294.56M |
| May 13, 2024 | 263.88M |
| May 10, 2024 | 260.01M |
| May 09, 2024 | 265.07M |
| May 08, 2024 | 259.41M |
| May 07, 2024 | 262.39M |
| May 06, 2024 | 263.29M |
| May 03, 2024 | 266.86M |
| May 02, 2024 | 260.61M |
| May 01, 2024 | 231.72M |
| April 30, 2024 | 229.33M |
| April 29, 2024 | 219.80M |
| April 26, 2024 | 204.61M |
| April 25, 2024 | 192.84M |
| April 24, 2024 | 207.54M |
| April 23, 2024 | 204.60M |
| April 22, 2024 | 210.77M |
| April 19, 2024 | 201.37M |
| April 18, 2024 | 196.07M |
| April 17, 2024 | 213.12M |
| April 16, 2024 | 227.53M |
| April 15, 2024 | 248.11M |
| Date | Value |
|---|---|
| April 12, 2024 | 264.57M |
| April 11, 2024 | 267.21M |
| April 10, 2024 | 264.27M |
| April 09, 2024 | 263.98M |
| April 08, 2024 | 268.39M |
| April 05, 2024 | 280.44M |
| April 04, 2024 | 268.39M |
| April 03, 2024 | 259.86M |
| April 02, 2024 | 252.81M |
| April 01, 2024 | 251.63M |
| March 28, 2024 | 230.17M |
| March 27, 2024 | 233.41M |
| March 26, 2024 | 225.45M |
| March 25, 2024 | 240.72M |
| March 22, 2024 | 255.43M |
| March 21, 2024 | 252.93M |
| March 20, 2024 | 238.77M |
| March 19, 2024 | 227.94M |
| March 18, 2024 | 181.58M |
| March 15, 2024 | 187.41M |
| March 14, 2024 | 174.08M |
| March 13, 2024 | 186.02M |
| March 12, 2024 | 182.97M |
| March 11, 2024 | 192.13M |
| March 08, 2024 | 212.40M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
28.82M
Minimum
Mar 18 2020
366.12M
Maximum
Feb 16 2023
145.49M
Average
146.74M
Median
Jan 22 2024
Market Cap Benchmarks
| Perspective Therapeutics Inc | 996.21M |
| Eli Lilly and Co | 731.81B |
| Cellectar Biosciences Inc | 118.30M |
| Outlook Therapeutics Inc | 181.26M |
| Bristol-Myers Squibb Co | 89.25B |
Market Cap Related Metrics
| PEG Ratio | -0.1595 |
| Price to Book Value | 6.655 |
| Price | 9.80 |
| Earnings Yield | -17.45% |
| PEGY Ratio | -0.1595 |